ABSTRACT
Introduction: Advanced laparoscopic procedures are performed in oncology for almost all visceral sites. We present theoncological and functional outcomes of series of patients who underwent advanced laparoscopic oncological procedures inour tertiary care center.Materials and Methods: We analyzed 34 consecutive patients who underwent advanced laparoscopic oncological proceduresby the same surgeon in the department of surgical oncology during the period of 2015–2019. Five patients underwentlaparoscopic type C1 radical hysterectomy. Laparoscopic abdominoperineal resection was done for six patients, laparoscopicstaging for carcinoma endometrium for seven patients, thoracoscopic esophagectomy for five patients, laparoscopic-assisteddistal gastrectomy for two patients, and laparoscopic staging for ovarian cancer for four patients. Laparoscopic right radicalnephrectomy and laparoscopic right hemicolectomy were done for one patient each.Results: Out of the five patients who underwent laparoscopic Type C1 radical hysterectomy, one patient had residual IB1disease. There was no bladder morbidity and all patients are alive without disease. Two patients who underwent laparoscopicabdominoperineal resection and one patient after thoracoscopic esophagectomy developed disease recurrence. None of thepatients who underwent other procedures had major morbidity or disease recurrence.Conclusion: Advanced laparoscopic procedures are feasible in oncology with minimal morbidity and good oncological outcome.The nodal yield and oncological outcome improve with increasing experience of the surgeon in minimally invasive surgicaloncology.